|
|
|
Insider
Information: |
Henneman John B III |
Relationship: |
Director |
City: |
|
State: |
|
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
8 |
|
Direct
Shares |
248,162 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$3,459,133 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
248,162 |
|
|
Total
Value |
$3,459,133 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
1
|
1
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
1
|
1
|
|
|
|
Gain/Loss Ratio : |
-1.0
|
-1.0
|
Percentage
Gain/Loss : |
-27.9%
|
-30.9%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Integra Lifesciences Holdings Corp |
IART |
CorpVP, CAO |
2014-08-25 |
34,159 |
2003-07-14 |
0 |
Premium* |
|
Lumos Pharma Inc |
LUMO |
Chief Administrative O... |
2018-10-01 |
55,052 |
2014-10-01 |
0 |
Premium* |
|
Seaspine Holdings Corp |
SPNE |
Director |
2023-01-05 |
0 |
2016-06-07 |
0 |
Premium* |
|
R1 RCM Inc |
ACHI |
Director |
2022-06-21 |
0 |
2016-08-16 |
0 |
Premium* |
|
Aprea Therapeutics, Inc. |
APRE |
Director |
2024-03-13 |
8,139 |
2019-10-07 |
0 |
Premium* |
|
Anika Therapeutics Inc |
ANIK |
Director |
2023-06-14 |
29,936 |
2020-09-03 |
0 |
Premium* |
|
R1 Rcm Inc |
RCM |
Director |
2023-08-08 |
72,114 |
2022-06-21 |
0 |
Premium* |
|
Orthofix International N.V. |
OFIX |
Director |
2023-01-05 |
48,762 |
2023-01-05 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
167 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 7
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
IART |
Integra Lifesciences Hold... |
Exec. VP, CAO, Secretary |
|
2003-07-14 |
4 |
OE |
$3.38 |
$16,175 |
D/D |
4,000 |
0 |
|
- |
|
IART |
Integra Lifesciences Hold... |
Exec. VP, CAO, & Secretary |
|
2003-08-11 |
4 |
OE |
$4.38 |
$17,500 |
D/D |
4,000 |
0 |
|
- |
|
IART |
Integra Lifesciences Hold... |
Exec VP, CAO, Secretary |
|
2003-09-08 |
4 |
OE |
$4.38 |
$17,500 |
D/D |
4,000 |
0 |
|
- |
|
IART |
Integra Lifesciences Hold... |
Exec VP, CAO, Secretary |
|
2003-10-13 |
4 |
OE |
$4.38 |
$17,500 |
D/D |
4,000 |
0 |
|
- |
|
IART |
Integra Lifesciences Hold... |
Exec. VP, CAO & Secretary |
|
2003-11-10 |
4 |
OE |
$4.38 |
$17,500 |
D/D |
4,000 |
0 |
|
- |
|
IART |
Integra Lifesciences Hold... |
Exec. VP, CAO & Secretary |
|
2003-12-08 |
4 |
OE |
$4.38 |
$17,500 |
D/D |
4,000 |
0 |
|
- |
|
IART |
Integra Lifesciences Hold... |
Exec. VP, CAO & Secretary |
|
2004-01-12 |
4 |
OE |
$4.38 |
$26,250 |
D/D |
6,000 |
0 |
|
- |
|
IART |
Integra Lifesciences Hold... |
Exec. VP, CAO & Secretary |
|
2004-02-09 |
4 |
OE |
$4.38 |
$26,250 |
D/D |
6,000 |
0 |
|
- |
|
IART |
Integra Lifesciences Hold... |
Exec. V.P. CAO & Secretary |
|
2004-03-08 |
4 |
OE |
$4.38 |
$26,250 |
D/D |
6,000 |
0 |
|
- |
|
IART |
Integra Lifesciences Hold... |
Exec. VP, CAO, Secretary |
|
2004-04-12 |
4 |
OE |
$4.38 |
$26,250 |
D/D |
6,000 |
0 |
|
- |
|
IART |
Integra Lifesciences Hold... |
Exec. VP, CAO, Secretary |
|
2004-05-10 |
4 |
OE |
$4.38 |
$26,250 |
D/D |
6,000 |
0 |
|
- |
|
IART |
Integra Lifesciences Hold... |
Exec. VP, CAO & Secretary |
|
2004-06-14 |
4 |
OE |
$4.38 |
$26,250 |
D/D |
6,000 |
0 |
|
- |
|
IART |
Integra Lifesciences Hold... |
Exec. VP, CAO & Secretary |
|
2004-07-12 |
4 |
S |
$33.50 |
$201,008 |
D/D |
(6,000) |
0 |
|
- |
|
IART |
Integra Lifesciences Hold... |
Exec.VP, CAO & Secretary |
|
2004-08-09 |
4 |
OE |
$4.38 |
$67,047 |
D/D |
15,325 |
0 |
|
- |
|
ACHI |
R1 RCM Inc |
Director |
|
2022-06-21 |
4 |
D |
$0.00 |
$0 |
D/D |
(54,751) |
0 |
0 |
- |
|
SPNE |
Seaspine Holdings Corp |
Director |
|
2023-01-05 |
4 |
D |
$0.00 |
$0 |
D/D |
(82,654) |
0 |
0 |
- |
|
APRE |
Aprea Therapeutics, Inc. |
Director |
|
2023-08-23 |
4 |
A |
$0.00 |
$0 |
D/D |
500 |
1,279 |
0 |
- |
|
APRE |
Aprea Therapeutics, Inc. |
|
|
2019-10-07 |
4 |
B |
$15.00 |
$75,000 |
D/D |
5,000 |
5,000 |
0.01 |
- |
|
APRE |
Aprea Therapeutics, Inc. |
Director |
|
2024-03-13 |
4 |
B |
$7.29 |
$50,009 |
D/D |
6,860 |
8,139 |
2.39 |
- |
|
ANIK |
Anika Therapeutics Inc |
Director |
|
2020-09-03 |
4 |
A |
$0.00 |
$0 |
D/D |
9,310 |
9,310 |
0 |
- |
|
APRE |
Aprea Therapeutics, Inc. |
Director |
|
2021-06-30 |
4 |
A |
$0.00 |
$0 |
D/D |
4,610 |
9,610 |
0 |
- |
|
ANIK |
Anika Therapeutics Inc |
Director |
|
2021-05-18 |
4 |
B |
$42.86 |
$85,720 |
D/D |
2,000 |
11,310 |
2.39 |
% |
|
ANIK |
Anika Therapeutics Inc |
Director |
|
2021-06-16 |
4 |
A |
$0.00 |
$0 |
D/D |
4,172 |
15,482 |
0 |
- |
|
APRE |
Aprea Therapeutics, Inc. |
Director |
|
2022-07-28 |
4 |
A |
$0.00 |
$0 |
D/D |
5,995 |
15,605 |
0 |
- |
|
IART |
Integra Lifesciences Hold... |
Exec. VP, CAO, Secretary |
|
2003-07-14 |
4 |
S |
$25.05 |
$100,329 |
D/D |
(4,000) |
18,367 |
|
- |
|
167 Records found
|
|
Page 1 of 7 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|